Western researchers overlook high-quality Chinese scientific publications despite China leading Nature index
By
The Economist
Summary
Chinese researchers published as many papers as researchers from the US, UK, Germany, and Japan combined in 2025, yet Western researchers largely ignore Chinese scientific output despite its high quality. China leads the Nature index for papers in respected journals, but cultural ignorance and a bad reputation are likely responsible for the lack of citations and attention from the West.
Source
bskyWestern researchers overlook high-quality Chinese scientific publications despite China leading Nature indexeconomist.comKey quotes
· 4 pulledChinese authors published as many papers as American, British, German and Japanese researchers combined in 2025.
Two recent analyses drawing on databases of tens of millions of English-language scientific articles suggest they were largely ignored by Western researchers.
That is not for lack of value: China leads the Nature index, a ranking of countries by number of papers published in a set of respected journals.
A bad reputation and cultural ignorance are probably responsible
You might also wanna read
Western researchers overlook high-quality Chinese scientific publications despite their volume and impact
Chinese authors published as many scientific papers in 2025 as researchers from the US, UK, Germany, and Japan combined, yet Western researc
economist.com·16d ago
China boosts prestigious grants for young scientists — will it ease competition?
How Chinese sci-tech workers drive innovation at grassroots posts
Transparent peer review to be extended to all of Nature's research papers
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussio
pocketcasts.com·12d ago
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussio
pca.st·13d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.